" Dr Morjaria was extremely professional and took her time to explain in detail every step of the procedure. The results were very good and I would not hesitate in recommending her."
" I received a thorough explanation and having seen many doctors previously, it was the first time my condition and treatments were explained in detail and clarity by Dr Morjaria. I highly recommend this doctor."
" Consultant was friendly and efficient, explained scans with the patient and asked patient if they had any questions. "
Rupal Morjaria specialises in medical retina diseases and cataract surgery. Her expertise includes the treatment of macular degeneration, diabetic eye disease, central serous retinopathy, retinal vein occlusions and inherited retinal disease such as retinitis pigmentosa. She has extensive experience in all retinal injection therapies (Eylea, Lucentis, Avastin, Ozurdex, Iluvien) as well as retinal laser treatments, including non-scarring sub-threshold retinal laser.
"world class care"
Rupal Morjaria studied medicine and qualified from Birmingham University in 2005. She underwent her specialist Ophthalmology training in the West Midlands Deanery, becoming a Fellow of the Royal College of Ophthalmologists. Rupal then completed a 3-year specialist fellowship in Medical Retina and Genetics, working alongsideProfessor Susan Downes at Oxford University and later at Moorfields Eye Hospital with Professor Andrew Webster. In 2018, Rupal was awarded a PhD from the University College London for her work on the impact of eye disease on sleep/wake patterns at Oxford University Hospitals.
"3 year specialist fellowship and PhD based at Oxford University Hospitals"
Rupal Morjaria worked as a Consultant in Medical Retina and Uveitis at the Queen Elizabeth Hospital in Birmingham prior to becoming a Medical Retina Consultant and the Lead Consultant in Retinal Genetics at the Birmingham and Midland Eye Centre, the second largest Specialist Ophthalmic unit in the UK.
"expertise in macular degeneration, diabetic eye disease, retinal vein occlusions and regional retinal genetic diseases"
Rupal Morjaria is an expert cataract surgeon and has experience in managing all manner of cataracts in particular, management of cataracts in patients with co-existing retinal disease. These patients often require additional treatment at the time of cataract surgery. Rupal's extensive training in world-class units has equipped her with up-to-date knowledge and expertise on current research and novel therapies and surgical skills to to provide outstanding care.
"expert cataract surgeon and deal with all manner of cataracts as well as simultaneous management of complex retinal disease"
Rupal Morjaria is the FOCUS lead for the Birmingham Midland Eye Centre, a Charity organisation which provides support to patients with visual impairment. She is also the current secretary of the Midland Ophthalmology Society.
30% of adults over 65 are estimated to have cataracts in the UK. Cataract surgery is the replacement of your natural opacified lens for a clear lens. It is the most common outpatient procedure carried out.
Diabetic retinopathy is the presence of fluid leakage and bleeding at the back of they eye due to poor blood sugar control. Treatment can help to preserve vision.
Retinal Vein Occlusion
This results in loss of vision from a blockage in one of the main retinal vessels or a branch resulting in fluid leakage and bleeding into the eye. Laser treatment and injections into the eye can help to preserve vision or prevent complete loss of vision.
Dry and Wet Macular degeneration are common causes of blindness. There are many factors that can predispose you to getting this. Treatment can be given to delay loss of vision from wet macular degeneration including anti-VEGF injections.
Central Serous Retinopathy
This is a condition causing central distortion as a result of fluid accumulation under the retina. In most people it improves within a short time period, however some require investigation and treatment.
Retinitis Pigmentosa is a general term for a range of genetic retinal conditions which results in early loss of central or peripheral vision.
Yag Laser Capsulotomy
This is a simple commonly performed procedure within 1 to 5 years after cataract surgery to polish the lens.
Retinal injections include anti-VEGF injections such as Lucentis (Ranibizumab), Eylea (Aflibercept), Avastin (Bevacizumab) and steroid injections; triamcinolone, ozurdex (dexamethasone implant) and Iluvien (fluoncinolone implant) are used to treat sight threatening conditions.
Royal College of Ophthalmologists
British Medical Association
Medical Defence Union
UK Eye Genetics group
Midland Ophthalmology Society
Ophthalmology Honours Award Honouree
West Midlands Trainee Award Nominee
Midland Ophthalmology Society Travel Award for the best Oral Presentation.
MidlandOphthalmology Society Travel Award for the best Poster Presentation.
Midlands Roper Hall Prize “Runner up” for Oral Presentation.
Contact Rupal Morjaria.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.